The profound inhibitory effect of Tanshinone IIA (Tan IIA) on atherosclerosis has been demonstrated, whereas the latent mechanism is not completely cleared. This study aimed to investigate the cellular and molecular mechanisms underlying Tan IIA protecting against atherosclerosis. Oil Red O staining and ELISA assay showed that Tan IIA suppressed the progress of atherosclerosis and reduced the levels of inflammatory cytokines in serum of apolipoprotein E deficient (ApoE–/–) mice. Flow cytometry assay revealed that Tan IIA inhibited oxidized LDL (ox-LDL)-induced apoptosis of VSMCs. MTT and transwell assay indicated that Tan IIA suppressed the ox-LDL-stimulated proliferation and migration of RAW264.7 cells. Moreover, Tan IIA ameliorated inflam...
Background: Tanshinone IIA inhibits the proliferation of pulmonary artery smooth muscle cells (PASMC...
Pathological angiogenesis, as exhibited by aberrant vascular structure and function, has been well d...
Anti-inflammation via inhibition of NF-κB pathways in hepatic stellate cells (HSCs) is one therapeut...
Tanshinone II-A (Tan), a bioactive diterpene isolated from Salvia miltiorrhiza Bunge (Danshen), poss...
Lectin-like oxidized LDL (oxLDL) receptor-1 (LOX-1), a novel scavenger receptor highly expressed in ...
Accumulation of foam cells in the neointima represents a key event in atherosclerosis. We previously...
Lectin-like oxidized LDL (oxLDL) receptor-1 (LOX-1), a novel scavenger receptor highly expressed in ...
Tanshinone IIA (Tan II A) is widely used in the treatment of cardiovascular diseases as an active co...
Aims: Estrogen plays a protective role in atherosclerosis. Our preliminary work demonstrated that th...
Background: Tanshinone IIA (TIIA) is the major lipid-soluble active ingredient of the traditional Ch...
Tanshinone IIA (Tan IIA) is a fat-soluble compound extracted from Salvia miltiorrhiza, which has a p...
Background/Aims: Tanshinone IIA (Tan IIA) is effective in the treatment of inflammation and atherosc...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Tanshinone IIA (TSA), a pharmacologically active component isolated from Danshen, may prevent cardio...
Objective(s): Vascular smooth muscle cells (VSMCs) play a key role in the pathogenesis of diabetic v...
Background: Tanshinone IIA inhibits the proliferation of pulmonary artery smooth muscle cells (PASMC...
Pathological angiogenesis, as exhibited by aberrant vascular structure and function, has been well d...
Anti-inflammation via inhibition of NF-κB pathways in hepatic stellate cells (HSCs) is one therapeut...
Tanshinone II-A (Tan), a bioactive diterpene isolated from Salvia miltiorrhiza Bunge (Danshen), poss...
Lectin-like oxidized LDL (oxLDL) receptor-1 (LOX-1), a novel scavenger receptor highly expressed in ...
Accumulation of foam cells in the neointima represents a key event in atherosclerosis. We previously...
Lectin-like oxidized LDL (oxLDL) receptor-1 (LOX-1), a novel scavenger receptor highly expressed in ...
Tanshinone IIA (Tan II A) is widely used in the treatment of cardiovascular diseases as an active co...
Aims: Estrogen plays a protective role in atherosclerosis. Our preliminary work demonstrated that th...
Background: Tanshinone IIA (TIIA) is the major lipid-soluble active ingredient of the traditional Ch...
Tanshinone IIA (Tan IIA) is a fat-soluble compound extracted from Salvia miltiorrhiza, which has a p...
Background/Aims: Tanshinone IIA (Tan IIA) is effective in the treatment of inflammation and atherosc...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Tanshinone IIA (TSA), a pharmacologically active component isolated from Danshen, may prevent cardio...
Objective(s): Vascular smooth muscle cells (VSMCs) play a key role in the pathogenesis of diabetic v...
Background: Tanshinone IIA inhibits the proliferation of pulmonary artery smooth muscle cells (PASMC...
Pathological angiogenesis, as exhibited by aberrant vascular structure and function, has been well d...
Anti-inflammation via inhibition of NF-κB pathways in hepatic stellate cells (HSCs) is one therapeut...